Engaging seasoned entrepreneurs proactively looking to start, and run, new ventures for the purpose of commercializing promising Rutgers technologies
About the Program
The successful commercialization of novel technologies requires the coupling of scientific/technical expertise with entrepreneurial experience and drive. The Entrepreneur-in-Residence (EIR) program aims to increase the probability of success of Rutgers startups, by pairing scientific teams with experienced business founders.
The Role of EIRs
Entrepreneurs-In-Residence (EIR) are given access to both the complete portfolio of Rutgers technologies and the inventors behind those technologies. Each EIR is encouraged to identify a promising technology in his/her areas of expertise, and team up with the inventor(s) to become the management nucleus of the startup.
How EIRs Can Help
EIRs engage in:
- Evaluating Rutgers IP assets as the potential core for a new start-up;
- Choosing a commercially viable technology to focus their efforts on;
- Developing—in partnership with the Rutgers inventor(s) and staff—a business plan, a funding plan, and an R&D road map for the chosen technology;
- Constituting the startup;
- Negotiating—on behalf of the startup—for a license to the IP from Rutgers; and
- Leading the startup’s fundraising, and product business development activities.
Traits of an EIR
- A track-record as an entrepreneur and executive;
- Experience building successful partnerships with academic teams (either in a startup, licensing, sponsored research, or another capacity);
- A strong drive to be in an entrepreneurial environment;
- Experience in raising dilutive and non-dilutive capital; and
- An extensive professional network.
Bruce is an accomplished executive and entrepreneur, with over 25 years of experience in life sciences. He has held leadership positions in early- to developmental- and IPO-stage companies.
Brian is a successful entrepreneur and investor, with over 20 years of experience in launching and transforming startups into revenue-generating enterprises.
Daniel is an experienced Enterprise software CEO with a track record of success building, growing and exiting global technology companies. Daniel was also a founding partner of New Venture Partners, a venture capital firm with $700 million under management (formerly Lucent New Ventures).
Wayne is an expert in strategic planning and business development, with particular interest in the commercialization of technology driven products and services for the pharmaceutical, nutrition and personal care industries.
Gregg is an accomplished operating executive with extensive experience in early-stage, venture-backed technology companies. He has held senior-level executive and operating positions in companies at all stages of development from pre-seed and seed-stage through to IPO.